Alternatives to Neuroscreen

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.

Firefly Neuroscience provides objective brain function assessments for mental illness using FDA-cleared Brain Network Analytics (BNA™) technology.

Aiforia provides AI-powered image analysis solutions for pathology, assisting pathologists and scientists in preclinical and clinical labs.

Develops a brain-computer interface for treating epilepsy.

AI-powered platform to predict and prevent adverse drug reactions, reducing hospitalizations.

Saluda Medical is a commercial-stage medical device company that develops treatments for chronic neurological conditions.

AI-powered EEG device for rapid seizure detection in critical care.

Develops and commercializes minimally invasive robotic platforms for the neuroscience field.

AI-powered cancer detection and therapy solutions for early diagnosis and personalized risk assessment.

Axonica Labs is developing AI-powered solutions for brain health, focusing on early detection and personalized interventions for neurological conditions.

Wearable devices and AI for continuous health monitoring and early disease detection.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

FIZE Medical is developing a novel, non-invasive device for early detection of neurological diseases.

AI-powered diagnostic system for predictive analytics in healthcare.

DNA Medtech develops advanced diagnostic tools for personalized medicine and disease detection.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.